Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 53,710 | 54,755 | 54,642 | 53,370 | 53,442 |
| Accounts receivable | 36,417 | -57,523 | -56,486 | -26,803 | 6,534 |
| Other Working Capital | -59,400 | 57,125 | 40,814 | -43,567 | -9,588 |
| Other Operating Activity | 294,811 | 385,757 | 363,061 | 289,832 | 235,895 |
| Operating Cash Flow | $325,538 | $440,114 | $402,031 | $272,832 | $286,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,840 | -24,881 | -21,191 | -23,353 | -30,035 |
| Net Acquisitions | 0 | -19,697 | -3,079 | -7,505 | -103,183 |
| Purchase Of Investment | -1,350 | -1,239 | -6,964 | -9,080 | -5,181 |
| Sale Of Investment | 23,103 | 750 | 0 | 0 | 250 |
| Purchase Sale Intangibles | -1,767 | -1,442 | -1,918 | -1,205 | -10,831 |
| Investing Cash Flow | $2,146 | $-46,509 | $-33,152 | $-41,143 | $-148,980 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 0 | 105,000 |
| Debt Repayment | -30,000 | -300,000 | -220,000 | -130,000 | -185,000 |
| Common Stock Issued | 8,383 | 27,695 | 4,892 | 19,524 | 983 |
| Common Stock Repurchased | -50,005 | -50,004 | -50,000 | N/A | N/A |
| Dividend Paid | -77,891 | -70,553 | -70,492 | -70,678 | -70,597 |
| Other Financing Activity | -1,244 | -421 | -314 | -57,804 | -1,518 |
| Financing Cash Flow | $-150,757 | $-393,283 | $-335,914 | $-238,958 | $-151,132 |
| Exchange Rate Effect | 11,073 | 129 | -5,302 | 8,416 | -4,962 |
| Beginning Cash Position | 238,361 | 237,910 | 210,247 | 209,100 | 227,891 |
| End Cash Position | 426,361 | 238,361 | 237,910 | 210,247 | 209,100 |
| Net Cash Flow | $176,927 | $322 | $32,965 | $-7,269 | $-13,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | 325,538 | 440,114 | 402,031 | 272,832 | 286,283 |
| Capital Expenditure | -19,607 | -26,323 | -23,109 | -24,558 | -40,866 |
| Free Cash Flow | 305,931 | 413,791 | 378,922 | 248,274 | 245,417 |